Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2021 Filed Nov 30, 2021 20:07 UTC |
WALDRON RICHARD AChief Financial Officer
|
SaleCommon Stock | 3,669 | $24.29 | $89,101.67 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 2 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,296 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $23.82 to $24.79. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Dec 1, 2021 01:04 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 9,082 | $26.04 | $236,449.87 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 3 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400,890 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $24.85 to $25.70. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Dec 1, 2021 01:04 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 15,861 | $24.29 | $385,184.39 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409,972 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $23.82 to $24.79. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Nov 30, 2021 20:06 UTC |
Smith Scott AndrewDirector · President
|
SaleCommon Stock | 249 | $26.04 | $6,482.72 |
DisclosureSEC source: 0001209191-21-067219 · doc4.xml · nonDerivative · entry 3 Smith Scott Andrew · CIK 0001614975 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,611 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $24.85 to $25.70. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Nov 30, 2021 20:06 UTC |
Smith Scott AndrewDirector · President
|
SaleCommon Stock | 435 | $24.29 | $10,563.98 |
DisclosureSEC source: 0001209191-21-067219 · doc4.xml · nonDerivative · entry 2 Smith Scott Andrew · CIK 0001614975 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,860 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $23.82 to $24.79. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Dec 1, 2021 01:07 UTC |
Vasquez ChristianSee Remarks
|
SaleCommon Stock | 401 | $26.04 | $10,440.04 |
DisclosureSEC source: 0001209191-21-067220 · doc4.xml · nonDerivative · entry 3 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,630 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $24.85 to $25.70. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Dec 1, 2021 01:07 UTC |
Vasquez ChristianSee Remarks
|
SaleCommon Stock | 699 | $24.29 | $16,975.22 |
DisclosureSEC source: 0001209191-21-067220 · doc4.xml · nonDerivative · entry 2 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,031 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $23.82 to $24.79. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Dec 1, 2021 01:05 UTC |
Sievers EricChief Medical Officer
|
SaleCommon Stock | 118 | $26.24 | $3,095.73 |
DisclosureSEC source: 0001209191-21-067218 · doc4.xml · nonDerivative · entry 1 Sievers Eric · CIK 0001835116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,056 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Nov 30, 2021 20:07 UTC |
WALDRON RICHARD AChief Financial Officer
|
SaleCommon Stock | 3,626 | $26.24 | $95,128.11 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,965 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Dec 1, 2021 01:04 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 15,675 | $26.24 | $411,233.63 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,425,833 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Nov 30, 2021 20:06 UTC |
Smith Scott AndrewDirector · President
|
SaleCommon Stock | 430 | $26.24 | $11,281.05 |
DisclosureSEC source: 0001209191-21-067219 · doc4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,295 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Dec 1, 2021 01:07 UTC |
Vasquez ChristianSee Remarks
|
SaleCommon Stock | 691 | $26.24 | $18,128.39 |
DisclosureSEC source: 0001209191-21-067220 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,730 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 21:09 UTC |
STEINMAN LAWRENCEDirector
|
SaleCommon Stock | 450 | $30.00 | $13,500.00 |
DisclosureSEC source: 0001209191-21-062747 · doc4.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,459 F1 · kind: Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 01, 2021 Filed Oct 7, 2021 22:08 UTC |
Sievers EricChief Medical Officer
|
SaleCommon Stock | 592 | $30.39 | $17,993.43 |
DisclosureSEC source: 0001209191-21-059975 · doc4.xml · nonDerivative · entry 1 Sievers Eric · CIK 0001835116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,174 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $30.20 to $30.47. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| October 01, 2021 Filed Oct 7, 2021 18:09 UTC |
Smith Scott AndrewDirector · President
|
SaleCommon Stock | 2,994 | $30.18 | $90,351.44 |
DisclosureSEC source: 0001209191-21-059977 · doc4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,725 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $30.10 to $30.41. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 00:00 UTC |
Levy GuyDirector
|
GrantCommon Stock | 267,900 | $28.00 | $7,501,200.00 |
DisclosureSEC source: 0000899243-21-038500 · doc4.xml · nonDerivative · entry 1 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,115,817 F5 · kind: The shares of common stock were purchased from the issuer in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) promulgated thereunder. F1 · ownership.nature: The securities reported in this row are held by Soleus Capital Master Fund, L.P. ("Master Fund"). Soleus Capital, LLC is the sole general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy Levy is the sole managing member of Soleus Capital Group, LLC. Each of Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 18:05 UTC |
STEINMAN LAWRENCEDirector
|
SaleCommon Stock | 450 | $36.82 | $16,569.00 |
DisclosureSEC source: 0001209191-21-056574 · doc4.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,909 F1 · kind: Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 26, 2021 Filed Aug 31, 2021 01:42 UTC |
Sievers EricChief Medical Officer
|
SaleCommon Stock | 6,883 | $39.59 | $272,495.91 |
DisclosureSEC source: 0001209191-21-053993 · doc4.xml · nonDerivative · entry 1 Sievers Eric · CIK 0001835116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,766 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $39.50 to $40.29. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 21:43 UTC |
Smith Scott AndrewDirector · President
|
SaleCommon Stock | 13,849 | $40.89 | $566,227.44 |
DisclosureSEC source: 0001209191-21-053994 · doc4.xml · nonDerivative · entry 2 Smith Scott Andrew · CIK 0001614975 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,719 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $40.54 to $41.08. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 21:43 UTC |
Smith Scott AndrewDirector · President
|
SaleCommon Stock | 19,395 | $39.63 | $768,699.49 |
DisclosureSEC source: 0001209191-21-053994 · doc4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,568 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $39.50 to $40.29. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| August 24, 2021 Filed Aug 27, 2021 00:05 UTC |
Levy GuyDirector
|
SaleCommon Stock | 207,640 | $39.65 | $8,232,926.00 |
DisclosureSEC source: 0000899243-21-034323 · doc4.xml · nonDerivative · entry 3 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 847,917 F3 · ownership.nature: 3. The securities reported in this row are held by Soleus Capital Master Fund, L.P. ("Master Fund"). Soleus Capital, LLC is the sole general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy Levy is the sole managing member of Soleus Capital Group, LLC. Each of Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| August 24, 2021 Filed Aug 27, 2021 00:05 UTC |
Levy GuyDirector
|
SaleCommon Stock | 53,195 | $39.65 | $2,109,181.75 |
DisclosureSEC source: 0000899243-21-034323 · doc4.xml · nonDerivative · entry 2 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 217,358 F2 · ownership.nature: The securities reported in this row are held by Soleus BA SPV, LLC ("Soleus SPV "). Soleus GP is the sole managing member of Soleus SPV. Soleus GP holds voting and dispositive power over the shares held by Soleus SPV. Soleus PE GP is the sole manager of Soleus GP. Mr. Guy Levy is the sole managing member of Soleus PE GP. Each of Soleus GP, Soleus PE GP and Mr. Guy Levy disclaims beneficial ownership of these securities held by Soleus SPV and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| August 24, 2021 Filed Aug 27, 2021 00:05 UTC |
Levy GuyDirector
|
SaleCommon Stock | 285,874 | $39.65 | $11,334,904.10 |
DisclosureSEC source: 0000899243-21-034323 · doc4.xml · nonDerivative · entry 1 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,167,378 F1 · ownership.nature: The securities reported in this row are owned directly by Soleus Private Equity Fund I, L.P. ("Soleus PE"). Soleus Private Equity GP I, LLC ("Soleus GP") is the sole general partner of Soleus PE. Soleus GP holds voting and dispositive power over the shares held by Soleus PE. Soleus PE GP I, LLC ("Soleus PE GP") is the sole manager of Soleus GP. Mr. Guy Levy is the sole managing member of Soleus PE GP. Each of Mr. Guy Levy, Soleus PE GP and Soleus GP disclaims beneficial ownership of these securities held by Soleus PE and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:41 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,747 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053513 · doc4.xml · derivative · entry 7 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 7,747 shares Expires 2030-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The option grant was reported by the Reporting Person's spouse on her Form 4 filed with the SEC on December 17, 2020. F3 · derivative.exercise_date: The Option is fully vested. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:41 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 4,533 | $41.60 | $188,572.80 |
DisclosureSEC source: 0001209191-21-053513 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 793,547 F1 · kind: Shares sold by the Reporting Person's spouse in payment of the aggregate option exercise price and withholding tax liability incurred upon the above-reported exercise of Option. F1 · shares: Shares sold by the Reporting Person's spouse in payment of the aggregate option exercise price and withholding tax liability incurred upon the above-reported exercise of Option. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:41 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionCommon Stock | 7,747 | $18.00 | $139,446.00 |
DisclosureSEC source: 0001209191-21-053513 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 798,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:48 UTC |
STEINMAN LAWRENCEDirector
|
SaleCommon Stock | 450 | $40.60 | $18,270.00 |
DisclosureSEC source: 0001209191-21-052295 · doc4.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,359 F1 · kind: Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 01:25 UTC |
STEINMAN LAWRENCEDirector
|
SaleCommon Stock | 450 | $38.29 | $17,230.50 |
DisclosureSEC source: 0001209191-21-047324 · doc4.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,809 F1 · kind: Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 07, 2021 Filed Jun 3, 2022 22:15 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 5,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034323 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,309,480 F1 · kind: These shares were received by the Reporting Person as part of a pro rata distribution-in-kind of Common Stock of the Issuer to the limited partners of an investment fund. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 23:39 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 1,700 | $39.89 | $67,819.97 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 4 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 790,333 F2 · shares: Represents shares of the Issuer's common stock sold by the reporting person's spouse to cover taxes due upon the release and settlement of her 138,461 RSUs. F5 · price: The range of prices for the shares of Common Stock is from $39.83 to $40.09. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 23:39 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 35,725 | $39.54 | $1,412,405.74 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 3 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 792,033 F2 · shares: Represents shares of the Issuer's common stock sold by the reporting person's spouse to cover taxes due upon the release and settlement of her 138,461 RSUs. F4 · price: The range of prices for the shares of Common Stock is from $38.83 to $39.82. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 23:39 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 17,575 | $38.24 | $672,147.09 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 827,758 F2 · shares: Represents shares of the Issuer's common stock sold by the reporting person's spouse to cover taxes due upon the release and settlement of her 138,461 RSUs. F3 · price: The range of prices for the shares of Common Stock is from $37.83 to $38.82. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:30 UTC |
Levy GuyDirector
|
SaleCommon Stock | 62,780 | $39.16 | $2,458,464.80 |
DisclosureSEC source: 0000899243-21-024991 · doc4.xml · nonDerivative · entry 2 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 270,553 F2 · ownership.nature: The securities reported in this row are held by Soleus BA SPV, LLC ("Soleus SPV "). Soleus GP is the sole managing member of Soleus SPV. Soleus GP holds voting and dispositive power over the shares held by Soleus SPV. Soleus PE GP is the sole manager of Soleus GP. Mr. Guy Levy is the sole managing member of Soleus PE GP. Each of Soleus GP, Soleus PE GP and Mr. Guy Levy disclaims beneficial ownership of these securities held by Soleus SPV and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:30 UTC |
Levy GuyDirector
|
SaleCommon Stock | 337,220 | $39.16 | $13,205,535.20 |
DisclosureSEC source: 0000899243-21-024991 · doc4.xml · nonDerivative · entry 1 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,453,252 F1 · ownership.nature: The securities reported in this row are owned directly by Soleus Private Equity Fund I, L.P. ("Soleus PE"). Soleus Private Equity GP I, LLC ("Soleus GP") is the sole general partner of Soleus PE. Soleus GP holds voting and dispositive power over the shares held by Soleus PE. Soleus PE GP I, LLC ("Soleus PE GP") is the sole manager of Soleus GP. Mr. Guy Levy is the sole managing member of Soleus PE GP. Each of Mr. Guy Levy, Soleus PE GP and Soleus GP disclaims beneficial ownership of these securities held by Soleus PE and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:39 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 19,269 | $39.22 | $755,753.30 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 845,333 F1 · price: The range of prices for the shares of Common Stock is from $39.00 to $39.62. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 01:22 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 4,068 | $40.08 | $163,058.46 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 15 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 864,602 F10 · price: The range of prices for the shares of Common Stock is from $40.00 to $40.25. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 01:22 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 31,349 | $39.33 | $1,232,858.99 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 14 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 868,670 F9 · price: The range of prices for the shares of Common Stock is from $39.00 to $39.83. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:27 UTC |
STEINMAN LAWRENCEDirector
|
GrantStock Option (right to buy) · Derivative | 12,307 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001209191-21-041216 · doc4.xml · derivative · entry 2 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,307 Underlying: Common Stock · 12,307 shares Expires 2031-06-15 F2 · derivative.exercise_date: 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:33 UTC |
Levy GuyDirector
|
GrantStock Option (right to buy) · Derivative | 12,307 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001209191-21-041226 · doc4.xml · derivative · entry 1 Levy Guy · CIK 0001812305 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,307 Underlying: Common Stock · 12,307 shares Expires 2031-06-15 F1 · derivative.exercise_date: 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:32 UTC |
GRAY MARY ANNDirector
|
GrantStock Option (right to buy) · Derivative | 12,307 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001209191-21-041224 · doc4.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,307 Underlying: Common Stock · 12,307 shares Expires 2031-06-15 F1 · derivative.exercise_date: 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:22 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 2 | $41.01 | $82.02 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 13 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 900,019 Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:22 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 12,348 | $40.27 | $497,304.59 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 12 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 900,021 F8 · price: The range of prices for the shares of Common Stock is from $40.00 to $40.99. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:22 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 19,673 | $39.36 | $774,272.23 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 11 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 912,369 F7 · price: The range of prices for the shares of Common Stock is from $39.00 to $39.97. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:34 UTC |
Moran SusanDirector
|
GrantStock Option (right to buy) · Derivative | 12,307 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001209191-21-041227 · doc4.xml · derivative · entry 1 Moran Susan · CIK 0001835225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,307 Underlying: Common Stock · 12,307 shares Expires 2031-06-15 F1 · derivative.exercise_date: 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 17:29 UTC |
MCBRINN SYLVIADirector
|
GrantStock Option (right to buy) · Derivative | 24,615 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001209191-21-041574 · doc4.xml · derivative · entry 1 MCBRINN SYLVIA · CIK 0001284666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,615 Underlying: Common Stock · 24,615 shares Expires 2031-06-15 F1 · derivative.exercise_date: 1/3 of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, and 1/36th of the total number of shares shall vest monthly thereafter, subject to the Optionee continuing to provide services to the Company through the vesting date. Read SEC document |
| June 15, 2021 Filed Jun 17, 2022 19:56 UTC Amendment |
MCBRINN SYLVIADirector
|
GrantStock Option (right to buy) · Derivative | 18,920 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001209191-22-038182 · doc4a.xml · derivative · entry 1 MCBRINN SYLVIA · CIK 0001284666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,920 Underlying: Common Stock · 18,920 shares Expires 2031-06-15 F1 · shares: On June 17, 2021, the reporting person filed a Form 4 in respect of an option covering 24,615 shares. Such option was granted on June 15, 2021 pursuant to the Company's non-employee director compensation policy. The Company subsequently determined that 5,695 of the shares comprising such award were null and void upon grant as a result of the $750,000 annual limit for non-employee director compensation under its 2020 Equity Incentive Plan. F2 · derivative.exercise_date: 1/3 of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, and 1/36th of the total number of shares shall vest monthly thereafter, subject to the reporting person continuing to provide services to the Company through the vesting date. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:23 UTC |
Sievers EricChief Medical Officer
|
OtherCommon Stock | 23,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041211 · doc4.xml · nonDerivative · entry 1 Sievers Eric · CIK 0001835116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,649 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:27 UTC |
STEINMAN LAWRENCEDirector
|
OtherCommon Stock | 5,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041216 · doc4.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,259 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 21:29 UTC |
WALDRON RICHARD AChief Financial Officer
|
OtherCommon Stock | 31,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041221 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,591 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC |
SHORT JAY M PHDDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 1,807 | $44.47 | $80,364.88 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 10 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 932,042 F6 · price: The range of prices for the shares of Common Stock is from $44.26 to $45.12. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.